WEIFANG, China, Nov. 27 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced its CFO, Mr. Philips Zhang, will be presenting at the Roth Capital Phoenix Conference on November 29, 2007.
The date, time and location of the Company's presentation at the
conference are as follows:
Date: Thursday, November 29, 2007
Time: 2:45 p.m. Mountain Time
Venue: Estrella West Room, The Royal Palms Resort, Phoenix, AZ
This two-day conference will feature presentations from management teams of more than 30 leading Chinese companies listed in the US. Interested parties and investors may find more information for the conference by visiting the website at http://www.rothcp.com .
About Shengtai Pharmaceutical, Inc.
Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the holding company for Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of glucose products, which include pharmaceutical grade glucose used for medical purposes, and glucose and cornstarch products for the food and beverage industry and for industrial production in China. For more information about Shengtai Pharmaceutical, Inc. please visit http://www.shengtaipharmaceutical.com .
Safe Harbor Statement
Safe Harbor Statement Under the Private Securities Litigation Reform
Act of 1995: Certain statements in this press release and oral statements
made by the Company, constitute forward-looking statements for purposes of
the safe harbor provisions under The Private Securities Litigation Reform
Act of 1995. These state
|SOURCE Shengtai Pharmaceutical, Inc.|
Copyright©2007 PR Newswire.
All rights reserved